The genetics of primary Sjögren’s syndrome

被引:23
|
作者
Amr H. Sawalha
Robyn Potts
Wendi R. Schmid
R. Hal Scofield
John B. Harley
机构
[1] Oklahoma Medical Research Foundation,Arthritis and Immunology Program
关键词
Systemic Lupus Erythematosus; Salivary Gland; Human Leukocyte Antigen; Human Leukocyte Antigen Class; Nonobese Diabetic Mouse;
D O I
10.1007/s11926-003-0012-x
中图分类号
学科分类号
摘要
Primary Sjögren’s syndrome is an autoimmune disease characterized clinically by dryness of the eyes and mouth. The use of different classification criteria for primary Sjögren’s syndrome has led to dramatically different esti-mates of prevalence and incidence. Despite this, several genetic and environmental factors are thought to play a role in the susceptibility to primary Sjögren’s syndrome, as is the current conceptual formulation of the pathogen-esis of many other autoimmune maladies. Primary Sjögren’s syndrome appears a complicated polygenic dis-order with many genes interacting with environmental factors. Similar to many other polygenic autoimmune rheumatic diseases, human leukocyte antigen associations have been reported and confirmed. Additionally, other non-human leukocyte antigen candidate genes have been reported to reveal association with primary Sjögren’s syndrome, but, in general, these effects are not con-firmed. The authors review the human leukocyte antigen and non-human leukocyte antigen genetic associations herewith, knowing that new technologies are providing access to the entire genome for association studies. No doubt a much more comprehensive description of the genetics of this disorder will soon emerge.
引用
收藏
页码:324 / 332
页数:8
相关论文
共 50 条
  • [41] Identification and verification of inflammatory biomarkers for primary Sjögren's syndrome
    Liu, Xiaodan
    Wang, Haojie
    Wang, Xiao
    Jiang, Xiaodan
    Jin, Yinji
    Han, Ying
    Zhang, Zhihui
    CLINICAL RHEUMATOLOGY, 2024, 43 (04) : 1335 - 1352
  • [42] Successful treatment of a patient with primary Sjögren's syndrome with Rituximab
    Troels Ring
    Maria Kallenbach
    Jeppe Prætorius
    Søren Nielsen
    Birgitte Melgaard
    Clinical Rheumatology, 2006, 25 : 891 - 894
  • [43] Nutrient intake in women with primary and secondary Sjögren's syndrome
    J M Cermak
    A S Papas
    R M Sullivan
    M R Dana
    D A Sullivan
    European Journal of Clinical Nutrition, 2003, 57 : 328 - 334
  • [44] Pulmonary and thymic lymphoid hyperplasia in primary Sjögren’s syndrome
    Hideo Kobayashi
    Yuichi Ozeki
    Shinsuke Aida
    Japanese Journal of Radiology, 2009, 27
  • [45] Altered expression of circular RNA in primary Sjögren’s syndrome
    Lin-Chong Su
    Wang-Dong Xu
    Xiao-Yan Liu
    Lu Fu
    An-Fang Huang
    Clinical Rheumatology, 2019, 38 : 3425 - 3433
  • [46] Identification and verification of inflammatory biomarkers for primary Sjögren’s syndrome
    Xiaodan Liu
    Haojie Wang
    Xiao Wang
    Xiaodan Jiang
    Yinji Jin
    Ying Han
    Zhihui Zhang
    Clinical Rheumatology, 2024, 43 : 1335 - 1352
  • [47] IkBα Promoter Polymorphisms in Patients with Primary Sjögren’s Syndrome
    Tsan-Teng Ou
    Chia-Hui Lin
    Yu-Chih Lin
    Ruei-Nian Li
    Wen-Chan Tsai
    Hong-Wen Liu
    Jeng-Hsien Yen
    Journal of Clinical Immunology, 2008, 28 : 440 - 444
  • [48] Clinical manifestations of neurological involvement in primary Sjögren’s syndrome
    Takahisa Gono
    Yasushi Kawaguchi
    Yasuhiro Katsumata
    Kae Takagi
    Akiko Tochimoto
    Sayumi Baba
    Yuko Okamoto
    Yuko Ota
    Hisashi Yamanaka
    Clinical Rheumatology, 2011, 30 : 485 - 490
  • [49] Adrenomedullary Response to Glucagon in Patients with Primary Sjögren’s Syndrome
    Richard Imrich
    Nikolay P. Nikolov
    Lolita Bebris
    Ilias Alevizos
    David S. Goldstein
    Courtney S. Holmes
    Gabor G. Illei
    Cellular and Molecular Neurobiology, 2012, 32 : 903 - 906
  • [50] Cytokine concentrations in stimulated whole saliva among patients with primary Sjögren's syndrome, secondary Sjögren's syndrome, and patients with primary Sjögren's syndrome receiving varying doses of interferon for symptomatic treatment of the condition: A preliminary study
    Streckfus C.
    Bigler L.
    Navazesh M.
    Al-Hashimi I.
    Clinical Oral Investigations, 2001, 5 (2) : 133 - 135